GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Dimerix Ltd (ASX:DXB) » Definitions » Issuance of Stock

Dimerix (ASX:DXB) Issuance of Stock : A$26.34 Mil (TTM As of Dec. 2024)


View and export this data going back to 1993. Start your Free Trial

What is Dimerix Issuance of Stock?

Dimerix's Issuance of Stock for the six months ended in Dec. 2024 was A$1.29 Mil.

Dimerix's Issuance of Stock for the trailing twelve months (TTM) ended in Dec. 2024 was A$26.34 Mil.


Dimerix Issuance of Stock Historical Data

The historical data trend for Dimerix's Issuance of Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dimerix Issuance of Stock Chart

Dimerix Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Issuance of Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.34 0.05 20.68 8.73 25.71

Dimerix Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Issuance of Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 0.66 25.05 1.29

Dimerix Issuance of Stock Calculation

A company may raise cash from issuing new shares. Issuance of Stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Issuance of Stock for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$26.34 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Dimerix Issuance of Stock Related Terms

Thank you for viewing the detailed overview of Dimerix's Issuance of Stock provided by GuruFocus.com. Please click on the following links to see related term pages.


Dimerix Business Description

Traded in Other Exchanges
Address
425 Smith Street, Fitzroy, VIC, AUS, 3065
Dimerix Ltd is a biopharmaceutical company developing new therapies in areas with unmet medical needs. The company is developing four product candidates: DMX-200 for FSGS; DMX-200 for diabetic kidney disease; DMX-200 for ARDS associated with COVID-19; and DMX-700 for COPD; as well as the proprietary ReceptorHIT assay technology.

Dimerix Headlines

No Headlines